Table 4 Cox proportional hazard analysis and competing risks analysis of pure APD and pure CAPD patients.
Pure APD vs. Pure CAPD outcomes | Cox proportional hazard analysis | Competing risks analysis | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate | Multivariate * | Univariate | Multivariate*,† | |||||||||
HR | 95% CI | p-value | HR | 95% CI | p-value | HR | 95% CI | p-value | HR | 95% CI | p-value | |
2001–2010, APD (n = 2,184) vs. CAPD (n = 2,244) | ||||||||||||
All-cause mortality | 1.20 | 1.06–1.36 | <0.01 | 1.21 | 1.06–1.37 | <0.01 | 1.16 | 1.02–1.32 | 0.02 | 1.15 | 1.01–1.31 | 0.04 |
Technique failure | 1.16 | 0.99–1.35 | 0.05 | 1.21 | 1.04–1.41 | 0.02 | 1.13 | 0.97–1.31 | 0.13 | 1.15 | 0.98–1.33 | 0.08 |
2001–2004, APD (n = 369) vs. CAPD (n = 390) | ||||||||||||
All-cause mortality | 1.17 | 0.90–1.52 | 0.23 | 1.16 | 0.89–1.51 | 0.29 | 1.18 | 0.91–1.53 | 0.22 | 1.13 | 0.85–1.48 | 0.40 |
Technique failure | 0.77 | 0.57–1.05 | 0.10 | 0.74 | 0.54–1.01 | 0.06 | 0.75 | 0.55–1.02 | 0.07 | 0.74 | 0.54–1.01 | 0.05 |
2005–2007, APD (n = 581) vs. CAPD (n = 595) | ||||||||||||
All-cause mortality | 1.43 | 1.15–1.78 | 0.001 | 1.54 | 1.24–1.93 | 0.001 | 1.31 | 1.06–1.63 | 0.01 | 1.39 | 1.11–1.75 | <0.01 |
Technique failure | 1.59 | 1.22–2.08 | 0.001 | 1.63 | 1.25–2.13 | <0.001 | 1.47 | 1.12–1.91 | <0.01 | 1.47 | 1.12–1.92 | <0.01 |
2008–2010, APD (n = 1,234) vs. CAPD (n = 1,259) | ||||||||||||
All-cause mortality | 1.06 | 0.87–1.29 | 0.58 | 1.00 | 0.82–1.22 | 0.98 | 1.04 | 0.86–1.27 | 0.66 | 0.99 | 0.81–1.22 | 0.97 |
Technique failure | 1.17 | 0.92–1.48 | 0.20 | 1.25 | 0.98–1.59 | 0.07 | 1.16 | 0.92–1.47 | 0.21 | 1.20 | 0.95–1.51 | 0.13 |
